Human Papilloma Virus (HPV) - Vaccination of boys and girls
80% of people become infected with human papillomaviruses (HPV) at some point in their lives. Initially, an infection often goes unnoticed because it usually causes no symptoms. In most cases, the infection clears on its own without any health consequences. However, about 20% of infections persist for a longer period and can lead to health problems, such as cellular changes in the mucous membranes and skin. Over time, these changes may, in some individuals, lead to cancer in the genital or oral-throat area.
HPV is transmitted through intimate contact, via tiny injuries to the skin and mucous membranes. The most effective preventive measure against the virus is vaccination against the most important HPV types. The younger the person receiving the vaccine, the better the immune system responds to it. The vaccine is approved from the age of 9. Up to the age of 15, only two doses are required, while after the 15th birthday, three doses are needed. Additionally, for individuals between the ages of 11 and 26, the costs are fully covered by health insurance (without a deductible) if the vaccination is administered through the cantonal vaccination program.
Therapeutic vaccines for individuals with a confirmed HPV infection are currently in development.
We would be happy to provide more detailed information as part of our girls’ consultation hour.
